返回
化工社化工社化学信息打印报告 · 仅供科研参考
HRID 106生成日期:2026年10月23日

4-苄氧基溴苯 → (R)-4-(4-benzyloxyphenyl)-3-methylpiperazine-1-carboxylic acid tert-butyl ester

https://huagongshe.com/zh-CN/reaction/106

反应方程式

参与物

角色名称HCID投料
反应物4-苄氧基溴苯HCID 138835—
反应物(R)-4-Boc-2-甲基哌嗪HCID 2756811—
试剂叔丁醇钾HCID 23665647—
催化剂三叔丁基膦HCID 83681—
催化剂二(三叔丁基膦)钯HCID 2734558—
溶剂四氢呋喃HCID 8028—
产物(R)-4-(4-benzyloxyphenyl)-3-methylpiperazine-1-carboxylic acid tert-butyl esterHCID 7087337535.73%

反应条件

温度150 °C

反应步骤

A mixture of 1-(benzyloxy)-4-bromobenzene (158 mg, 0.60 mmol), (R)-tert-butyl 3-methylpiperazine-1-carboxylate (60.1 mg, 0.3 mmol), bis(tri-t- butylphosphine)palladium(0) (15.33 mg, 0.03 mmol) and potassium tert-butoxide (37.0 mg, 0.33 mmol) in THF (2 mL) was flushed with nitrogen and sealed into a microwave tube. The reaction was heated to 150 °C for 20 minutes in the microwave reactor and cooled to RT. The reaction mixture was filtered and the filtrate evaporated to dryness. The residue was dissolved in MeOH (5mL) and purified by ion exchange chromatography, using an SCX column. The desired product was eluted from the column using 0.35M NH3/MeOH and pure fractions were evaporated to dryness. The crude product was purified by flash silica chromatography, elution gradient 0 to 20% EtOAc in isohexane. Pure fractions were evaporated to dryness to afford (R)-tert-butyl 4-(4-(benzyloxy)phenyl)-3-methylpiperazine-1-carboxylate (41.0 mg, 35.7 %) as a colourless oil that solidified on standing.

来源与证据

来源数据集750 AstraZeneca ELN dataset
ORD IDord-8459652e6963448495d966b232514570
来源说明750 AstraZeneca ELN dataset